LEVELS – A Whole New Level cover image

#283 - Brain health explained: Insulin resistance, biomarkers, and Alzheimer’s risk | Dr. David Perlmutter & Mike Haney

LEVELS – A Whole New Level

00:00

Do GLP-1s Hold Promise for Neurological Diseases?

Mike asks about GLP-1s; Perlmutter explains metabolic mechanisms and encouraging Parkinson's and Alzheimer’s signals.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app